Vitamin B5 Prices Rise 1.34 Percent in September
Pharmaceutical and supplement manufacturers face higher input costs as seasonal demand impacts fourth-quarter negotiations.
Updated on Oct. 26, 2026 in Economic Indicators
Live Poll
Do you expect prices for your dietary supplements to increase in the coming months?
US Vitamin B5 prices rose 1.34 percent in September 2026, driven by seasonal procurement efforts. The move impacts pharmaceutical manufacturers and supplement distributors heading into fourth-quarter contract negotiations.
Why it matters
The price hike reflects a combination of rising upstream feedstock costs for glucose and beta-alanine alongside persistent tariff pressure. For operators, this marks a tightening of margin control as seasonal restocking cycles drive temporary cost volatility.
Vitamin B5 prices rose 1.34% in September, weighed against a 25% Section 301 tariff on Chinese-origin imports. Approximately one-third of total US pantothenate consumption is currently attributed to the animal feed sector.
The players
Asian suppliers
The primary source of vitamin imports that have maintained consistent production rates while passing through higher feedstock and energy costs.
East Coast buyers
Regional commercial participants in the supplement and pharmaceutical supply chain currently driving demand via seasonal replenishment.
The details
Price increases were primarily driven by Asian suppliers holding firm on export offers to account for higher energy and feedstock costs. Meanwhile, East Coast buyers initiated replenishment cycles to secure inventory before the start of fourth-quarter negotiations. Although supply remains steady with normal operating rates at Chinese facilities, the convergence of procurement demand and import tariffs continues to dictate the current pricing environment.
Timeline
September 2026: US Vitamin B5 prices increased by 1.34 percent.
Early September 2026: East Coast buyers resumed routine replenishment buying.
Mid-September 2026: Asian suppliers maintained firm export offers.
Fourth-quarter 2026: Upcoming period for pharmaceutical and supplement contract negotiations.
Market Landscape
The current pricing shift follows a pattern of cost volatility exacerbated by the 25% Section 301 tariff on Chinese-origin vitamins. These import duties continue to fundamentally alter the cost basis for US-based pharmaceutical and supplement manufacturers.
Operators in the supplement and pharmaceutical space should factor these rising feedstock and import costs into upcoming fourth-quarter contract renewals. Monitor export offer stability from Asian suppliers, as tariff dynamics remain a primary cap on potential price relief.
The takeaway
Supply chain volatility remains high due to the confluence of seasonal restocking cycles and long-term tariff structures. Procurement managers should track weekly export offer trends from Asian suppliers to better time their contract lock-ins for the next fiscal year.
Further reading
For broader trends in supply chain costs and import pricing, monitor our Economic Indicators section.
Source note: This article includes information reported by Chemanalyst.
Live Poll
Do you expect prices for your dietary supplements to increase in the coming months?
